CHEMICAL IGF-I COMPOSITION FOR THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES

Application 1436/KOLNP/2004 published 2006-08-11, filed 2004-09-27
The invention relates to novel, sustained-release IGF-I therapeutic compositions, a preparation and production method thereof and the use of same in the production of medicaments for the treatment and prevention of neurodegenerative diseases such as, among others, Alzheimer's disease or cerebellar ataxia. The inventive compositions take the form of microspheres having a size of less than 5 micrometres, among other characteristics, and subcutaneous implantation capsules. (FIG. 2)

Applicant

(1) CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS & (2) UNIVERSIDAD COMPLUTENSE DE MADRID
(1) CALLE SERRANO, 117, E-28006 MADRID, SPAIN & (2) AVDA, DE SENECA, 2, E-28040 MADRID, SPAIN

Inventor

(1) LOPEZ LOPEZ CRISTINA (2) CARRO DIAZ EVA MARIA (3) TORRES ALEMAN IGNACIO (4) TORRADO DURAN JUAN JOSE (5) TORRADO DURAN SANTIAGO (6) CARRASCOSA CELIA

International Info

Classification: A61K 38/30
Publication Number: WO 03/077940A1- 25.09.2003
Application Date: 2003-02-21

Priority Information

P 200200491 SPAIN 2002-02-28